Collection Papers [0/1] Patents [0/11] Periodical Articles [193/194] Conference Papers/Meeting Abstract [41/48] Siblings Winston C.Y. Yu [19/19] Ko-Jiunn Liu [85/98] Tsang-Wu Liu [119/125] Jieh-Yuan Liou(2003-2010) [3/3] Her-Shyong Shiah(1996-2012) [26/31] Shine-Gwo Shiah [51/54] Nai-Jung Chiang [82/94] Hui-Ju Mandy Ch'ang [39/44] Kwang-Yu Chang [69/79] I-Shou Chang [103/106] Wun-Shaing Wayne Chang [52/53] Jeffrey Shu-Ming [89/91] Jacqueline Whang-Peng(1996-2007) [120/126] Neng-Yao Shih [37/43] Chia-Huei Lee [29/29] Alan Yueh-Luen Lee [48/49] Su-Fang Lin [32/32] Yi-Hsin Yang [41/42] Shih-Sheng Jiang [88/90] Che-Hung Shen [14/16] Wen-Chun Hung [88/88] Shuang-En Chuang [82/91] Kelvin Kun-Chih Tsai [32/34] Hui-Jen Tsai [66/71] Yung-Yeh Su [40/40] Jen-Liang Su [24/25] Ching-Chuan Kuo [71/76] Shang-Hung Chen [45/48] Jen-Yang Chen [72/72] Li-Tzong Chen [443/510] Mei-Shya Chen(2002-2009) [1/1] Shih-Cheng Chen [2/2] Ya-Wen Chen [38/39] Tze-Sing Huang [55/55] Dau-Yang Huang [26/26] Chou-Chik George Ting(2000-2004) [5/5] Others [464/471] Ming Jacqueline Liu(1996-2007) [60/62] Mei-Ying Liu(2004-2006) [2/2] Cheng-Wen Wu(1996-2008) [53/55] Szu-Wen Tseng(1997-2007) [4/4] Kuan-Te Li(1997-2004) [4/6] Ching-Tai Lin(1999-2007) [5/5] Wen-Kuang Yang(1996-1999) [21/21] Chuan-Cheng Wang(1996-2003) [4/4] Shin-Hun P. Juang(1997-2004) [11/11] Tzung-Huang Jan(2000-2008) [2/2] Gi-Ming Lai(2004-2008) [41/47] Li-Jung Juan(2000-2006) [6/7] Jim-Ray Chen(2003-2007) [6/6] Yen-Ying Ma(1997-1999) [1/1] Chi-Ying F. Huang(2005-2007) [9/10] Community Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:234(92.13%) Download counts of the item Download times greater than 0:234(100.00%) Download times greater than 100:234(100.00%) Total Bitstream Download Counts:146374(2.73%) Last Update: 2024-11-28 15:38 Top Upload Loading... Top Download Loading... Recent Submissions Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 254. (11 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-16	Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues	Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-01-12	Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells	Scientific Reports. 2021 Jan 12;11:Article number 644.
2020-08	The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells	Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
2020-07-17	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.]	Scientific Reports. 2020 Jul 17;10:Article number 12216.
2020-06-28	Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction	Cancers. 2020 Jun 28;12(7):Article number 1718.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2020-05-27	The tumor suppressor TGFBR3 blocks lymph node metastasis in head and neck cancer	Cancers. 2020 May 27;12(6):Article number 1375.
2020-04-02	MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer	Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
2020-03-31	Discoidin domain receptor-1 (DDR1) is involved in angiolymphatic invasion in oral cancer	Cancers. 2020 Mar 31;12(4):Article number 841.
2019-12	Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry	Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
2019-08-24	New insights into mechanisms of cisplatin resistance: From tumor cell to microenvironment	International Journal of Molecular Sciences. 2019 Aug 24;20(17):Article number 4136.
2019-07	Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942.
2019-06-01	Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells	International Journal of Cancer. 2019 Jun 1;144(11):2795-2810.
2019-06	Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial	Head and Neck. 2019 Jun;41(6):1703-1712.
2019-06	Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer	Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233.
2019-04	Oral hygiene and the overall survival of head and neck cancer patients	Cancer Medicine. 2019 Apr;8(4):1854-1864.
2019-03-20	TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility	PLoS ONE. 2019 Mar 20;14(3):Article number e0213463.
2019-03	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer	Scientific Reports. 2019 Mar;9:Article number 3931.
2019-02	The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients	Cancer Epidemiology, Biomarkers and Prevention. 2019 Feb;28(2):248-257.
2019-01-15	1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase	European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.

Showing items 1-25 of 254. (11 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page